BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.6//EN
X-ORIGINAL-URL:https://bnsorg.be/
X-WR-CALNAME:BNS
X-WR-CALDESC:Belgian Nuclear Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-533d2891bb1b332f3845f7bfd09b78ef@bnsorg.be
DTSTART:20230525T163000Z
DTEND:20230525T190000Z
DTSTAMP:20230323T115900Z
CREATED:20230323
LAST-MODIFIED:20230530
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Actinium-225, a weapon for the fight against cancer
DESCRIPTION:This virtual evening lecture will be given by Sven Van den Berghe, Chief Executive Officer of Pantera, a joint-venture between SCK CEN and IBA.\nhttps://www.sckcen.be/en/news/iba-and-sck-cen-launch-pantera\nThe potential of actinium-225\nActinium-225 possesses the resounding potential to treat cancers more effectively. Initial results show that the theranostic radioisotope completely eliminates cancer cells, rather than just inhibiting tumour growth. The risk of recurrence also appears to decrease. To date, extensive research and numerous studies are underway which aim to tackle both high prevalence cancers including prostate, lung, colon, breast, pancreatic, blood (leukemia and other rare forms) and kidney cancers, but also rarer forms of cancer like glioblastoma, the deadliest form of a very invasive brain cancer.\nPresentation material\nPlease log in ( https://bnsorg.be/login/ ) with your BNS member account to get access to the slides and to see the password for the video recording.\n2.13.0.02.13.0.0\n
URL:https://bnsorg.be/event/actinium-225-pantera/
CATEGORIES:Evening Lecture
LOCATION:Videoconference
ATTACH;FMTTYPE=image/png:https://bnsorg.be/wp-content/uploads/2023/03/2022_SCKCEN_Pantera.png
END:VEVENT
END:VCALENDAR